Eli Lilly Is Working on an Anti-Obesity Pill, Says CEO Dave Ricks

Eli Lilly is the world's most valuable drug company, partially known for blockbuster anti-obesity drugs that are transforming America. In an episode of "The David Rubenstein Show: Peer to Peer Conversations," CEO Dave Ricks talks about how GLP-1 anti-obesity medications work and Lilly's plans to develop a pill. Ricks also discusses the side effects that come from taking these drugs. This interview was recorded on December 10 at the Economic Club of Washington DC.
--------
Like this video? Subscribe to The David Rubenstein Show on YouTube:
/ @davidrubenstein

Watch the latest episodes of "The David Rubenstein Show: Peer-to-Peer Conversations" here:
https://www.bloomberg.com/peer-to-peer

Learn more about David:
http://www.davidrubenstein.com/
Connect with us on...
Twitter: / business
Facebook: / bloombergbusiness
Instagram: / bloombergbusiness